Ligand profile
CHEMBL593446
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_16560 — S-ribosylhomocysteine lyase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL593446- UniProt (similar protein)
O34667- pchembl
- 6.370 (~426.6 nM)
- Target protein
- KP13_16560
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 133.2
- −1 ≤ LogP ≤ 5 -2.04
- MW ≤ 500 Da 267.3
- LogP ≤ 5 -2.04
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 133.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N[C@@H](CCSC[C@H]1OC(O)[C@H](O)[C@@H]1O)C(=O)ON[C@@H](CCSC[C@H]1OC(O)[C@H](O)[C@@H]1O)C(=O)O
InChI=1S/C9H17NO6S/c10-4(8(13)14)1-2-17-3-5-6(11)7(12)9(15)16-5/h4-7,9,11-12,15H,1-3,10H2,(H,13,14)/t4-,5+,6+,7+,9?/m0/s1InChI=1S/C9H17NO6S/c10-4(8(13)14)1-2-17-3-5-6(11)7(12)9(15)16-5/h4-7,9,11-12,15H,1-3,10H2,(H,13,14)/t4-,5+,6+,7+,9?/m0/s1
IQFWYNFDWRYSRA-BLELIYKESA-NIQFWYNFDWRYSRA-BLELIYKESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF02664
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL593446 →
- UniProt UniProt O34667 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL593446”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_16560.
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).